US equities |
MU $1,025.96 ▼-1.87% NVDA $237.66 ▼-0.66% AMD $640.34 ▼-1.40% INTC $112.65 ▲+0.13% SPCX $168.65 ▼-1.90% SNDK $1,654.97 ▼-0.33% TSLA $377.00 ▼-0.97% AAPL $334.68 ▲+0.31%
FinancialContent

Latest News about TYPTF

Recent news which mentions TYPTF

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
Tickers NEWS TYPTF
Tags Psychedelics Research TRP/8803 Benzinga
From Benzinga